Renalytix Historical Financial Ratios

RNLX Stock  USD 0.13  0.02  13.33%   
Renalytix is promptly reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Average Payables of 0.0, Stock Based Compensation To Revenue of 1.28, Capex To Depreciation of 0.012 or Ev To Sales of 12.86 will help investors to properly organize and evaluate Renalytix AI financial condition quickly.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Renalytix Financial Ratios Analysis

Renalytix AIFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Renalytix investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Renalytix financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Renalytix history.

Renalytix Financial Ratios Chart

At this time, Renalytix's Stock Based Compensation To Revenue is fairly stable compared to the past year. Inventory Turnover is likely to rise to 3.56 in 2024, whereas Price To Sales Ratio is likely to drop 11.26 in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Renalytix AI stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Renalytix sales, a figure that is much harder to manipulate than other Renalytix AI multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Stock Based Compensation To Revenue

A metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Average Inventory

The average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels.
Most ratios from Renalytix's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Renalytix AI current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Renalytix AI. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At this time, Renalytix's Stock Based Compensation To Revenue is fairly stable compared to the past year. Inventory Turnover is likely to rise to 3.56 in 2024, whereas Price To Sales Ratio is likely to drop 11.26 in 2024.
 2021 2022 2023 2024 (projected)
Payables Turnover0.830.920.820.42
Days Of Inventory On Hand206.3496.99111.54105.96

Renalytix fundamentals Correlations

-0.640.580.070.790.780.7-0.641.00.670.58-0.880.430.86-0.89-0.640.99-0.18-0.680.76-0.75-0.670.640.260.64-0.68
-0.64-0.380.6-0.52-0.8-0.871.0-0.64-0.88-0.210.71-0.8-0.760.670.4-0.640.631.0-0.870.871.0-0.25-0.75-1.01.0
0.58-0.380.120.370.350.41-0.380.580.290.27-0.660.240.52-0.42-0.150.63-0.02-0.40.43-0.44-0.390.380.310.38-0.4
0.070.60.120.23-0.51-0.450.60.07-0.630.460.13-0.63-0.320.2-0.280.10.930.57-0.420.450.580.01-0.68-0.610.57
0.79-0.520.370.230.430.55-0.520.790.360.93-0.750.20.68-0.57-0.940.810.07-0.550.64-0.59-0.540.490.090.5-0.55
0.78-0.80.35-0.510.430.82-0.80.780.930.1-0.720.660.86-0.87-0.240.74-0.71-0.820.84-0.86-0.810.510.480.8-0.82
0.7-0.870.41-0.450.550.82-0.870.70.710.29-0.760.440.8-0.71-0.440.69-0.56-0.880.99-0.99-0.870.170.410.86-0.88
-0.641.0-0.380.6-0.52-0.8-0.87-0.64-0.88-0.210.71-0.8-0.760.670.4-0.640.631.0-0.870.871.0-0.25-0.75-1.01.0
1.0-0.640.580.070.790.780.7-0.640.670.57-0.880.440.86-0.89-0.630.99-0.18-0.680.76-0.75-0.670.640.260.64-0.68
0.67-0.880.29-0.630.360.930.71-0.880.670.01-0.620.880.76-0.76-0.190.63-0.73-0.880.73-0.75-0.880.440.690.88-0.88
0.58-0.210.270.460.930.10.29-0.210.570.01-0.56-0.10.44-0.31-0.940.610.34-0.240.38-0.32-0.230.39-0.140.19-0.24
-0.880.71-0.660.13-0.75-0.72-0.760.71-0.88-0.62-0.56-0.44-0.950.880.64-0.910.360.74-0.840.830.73-0.69-0.48-0.70.74
0.43-0.80.24-0.630.20.660.44-0.80.440.88-0.1-0.440.52-0.53-0.080.41-0.61-0.790.46-0.48-0.810.360.890.81-0.79
0.86-0.760.52-0.320.680.860.8-0.760.860.760.44-0.950.52-0.92-0.540.86-0.58-0.780.88-0.87-0.770.730.50.75-0.78
-0.890.67-0.420.2-0.57-0.87-0.710.67-0.89-0.76-0.310.88-0.53-0.920.47-0.880.470.7-0.780.780.69-0.71-0.45-0.670.7
-0.640.4-0.15-0.28-0.94-0.24-0.440.4-0.63-0.19-0.940.64-0.08-0.540.47-0.66-0.170.43-0.520.470.42-0.39-0.04-0.380.43
0.99-0.640.630.10.810.740.69-0.640.990.630.61-0.910.410.86-0.88-0.66-0.14-0.680.76-0.75-0.660.630.280.63-0.68
-0.180.63-0.020.930.07-0.71-0.560.63-0.18-0.730.340.36-0.61-0.580.47-0.17-0.140.61-0.570.60.61-0.28-0.64-0.640.61
-0.681.0-0.40.57-0.55-0.82-0.881.0-0.68-0.88-0.240.74-0.79-0.780.70.43-0.680.61-0.890.891.0-0.28-0.72-1.01.0
0.76-0.870.43-0.420.640.840.99-0.870.760.730.38-0.840.460.88-0.78-0.520.76-0.57-0.89-1.0-0.870.310.430.86-0.89
-0.750.87-0.440.45-0.59-0.86-0.990.87-0.75-0.75-0.320.83-0.48-0.870.780.47-0.750.60.89-1.00.87-0.3-0.45-0.870.89
-0.671.0-0.390.58-0.54-0.81-0.871.0-0.67-0.88-0.230.73-0.81-0.770.690.42-0.660.611.0-0.870.87-0.27-0.74-1.01.0
0.64-0.250.380.010.490.510.17-0.250.640.440.39-0.690.360.73-0.71-0.390.63-0.28-0.280.31-0.3-0.270.330.24-0.27
0.26-0.750.31-0.680.090.480.41-0.750.260.69-0.14-0.480.890.5-0.45-0.040.28-0.64-0.720.43-0.45-0.740.330.76-0.72
0.64-1.00.38-0.610.50.80.86-1.00.640.880.19-0.70.810.75-0.67-0.380.63-0.64-1.00.86-0.87-1.00.240.76-1.0
-0.681.0-0.40.57-0.55-0.82-0.881.0-0.68-0.88-0.240.74-0.79-0.780.70.43-0.680.611.0-0.890.891.0-0.27-0.72-1.0
Click cells to compare fundamentals

Renalytix Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.